In this week’s Video Forum, Pano Anthos, founder and managing director of XRC Ventures, talks about the investment firm’s work in the retailing, health care technology and CPG industries. He discusses XRC’s investment strategy, the criteria it uses to decide which start-up and early stage companies to work with, and the sectors that he sees as ripe for innovation.
Video Forum: Pano Anthos, XRC Ventures
In this week’s Video Forum, Pano Anthos, founder and managing director of XRC Ventures, talks about the investment firm’s work in the retailing, health care technology and CPG industries.
Related
Kroger-Albertsons merger goes on trial in an Oregon federal court
The FTC faces off against lawyers from Albertsons and Kroger in a fight over competition in the grocery channel.
FDA approves Moderna’s updated COVID-19 vaccine
Moderna's updated COVID-19 vaccine targets the KP.2 variant of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older.
Kroger sues FTC, claims merger challenge violates Constitution
The company argues that by proceeding in its administrative tribunal, in addition to the separate action in federal court, the FTC is violating Constitutional protections.
CRN to Federal Appeals Court: NY AG’s arguments don’t support denial of preliminary injunction in NY age restrictions case
CRN’s most recent brief argues that the NY AG does not meaningfully address CRN’s arguments about the Act’s constitutional infirmities.
Latest
PIM Brands names Cope and Hackett to leadership roles
PIM Brands strengthens its commercial team by adding CPG veterans Vanessa Cope and Joe Hackett.
Study: Most adults support vaccines, but many remain unclear about respiratory vaccine recommendations
NFID launches National Respiratory Communications Initiative to help deliver clear, consistent, evidence-based guidance on respiratory disease prevention.
Surescripts, Oracle Health team to help clear Rx barriers for patients nationwide
Prior Authorization Automation returns approvals within seconds when all criteria are met for available medications, helping patients start therapy sooner.
Walmart celebrates 20 years of $4 generics
Walmart is marking the 20th anniversary of its $4 generics program to highlight its broader push to make healthcare more accessible and affordable.